Similar Natural Products in NPASS
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient ![](images/questionmark.png)
●  The left chart: Distribution of similarity level between NPC472194 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 54 |
0.1-0.2 | 5368 |
0.2-0.3 | 20709 |
0.3-0.4 | 4351 |
0.4-0.5 | 356 |
0.5-0.6 | 45 |
0.6-0.7 | 5 |
0.7-0.8 | 1 |
0.8-0.85 | 0 |
0.85-0.9 | 0 |
0.9-0.95 | 0 |
0.95-1 | 0 |
  Similar Clinical/Approved Drugs
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC472194 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 74 |
0.1-0.2 | 571 |
0.2-0.3 | 5515 |
0.3-0.4 | 2847 |
0.4-0.5 | 141 |
0.5-0.6 | 12 |
0.6-0.7 | 1 |
0.7-0.8 | 0 |
0.8-0.85 | 0 |
0.85-0.9 | 0 |
0.9-0.95 | 0 |
0.95-1 | 0 |
Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.6222 |
Remote Similarity |
NPD529 |
Approved |
0.5769 |
Remote Similarity |
NPD210 |
Approved |
0.5769 |
Remote Similarity |
NPD211 |
Approved |
0.5745 |
Remote Similarity |
NPD5115 |
Clinical (unspecified phase) |
0.5698
|
Remote Similarity |
NPD3709 |
Clinical (unspecified phase) |